首页 > 最新文献

Journal of Clinical and Translational Science最新文献

英文 中文
Extending participant feedback beyond clinical studies: A modular system designed to connect researchers and participants. 将参与者反馈扩展到临床研究之外:设计用于连接研究人员和参与者的模块化系统。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-11-03 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10184
Alicia Giordimaina Carmichael, Donna Walter, Brandon Patric Labbree, Boluwatife Dogari, Natalie Leonard, Kathryn Ward, Xiaoya Geng, Medha Raju, Jess Francis-Levin, Richard Gonzalez

Introduction: Declining participant engagement threatens human subjects research. Participant feedback systems (PFS) may combat this decline by empowering participants to evaluate their research experiences and share that feedback with researchers to identify targets for improvement. PFS signal that participant experiences are prioritized, making the request for feedback itself an intervention. PFS design work remains largely confined to clinical research. This exploratory study investigates the design parameters of extending PFS to nonclinical research. We conducted focus groups with nonclinical stakeholders: Experienced research participants (ERP) and research team members (RTM).

Methods: ERP focus groups were organized by affinity (LGBTQIA+, BIPOC, persons with disabilities, neurodivergent, and a general group). RTM focus groups were organized by unit within the University of Michigan. Transcripts were analyzed using inductive thematic analysis.

Results: Ten focus groups (ERP: 5, n = 25; RTM: 5, n = 26) identified key PFS design considerations: (1) motivations for feedback, (2) feedback collection, and (3) feedback delivery. ERP and RTM collectively preferred anonymous web-based surveys with six potential topic areas: communication, respect, being valued, receiving value, burden, and safety. Feedback delivery faced two key design tensions: balancing institutional standardization with study-specific insights and aligning leadership's preference for high-level summaries with frontline staff's need for detailed, real-time feedback.

Conclusion: Expanding PFS to nonclinical research requires balancing centralization and study-specific flexibility. While centralization enhances consistency, the diversity of nonclinical studies necessitates adaptable implementation. A hybrid model is proposed to optimize feasibility. Future research should refine and test this model.

参与者参与度的下降威胁着人类受试者的研究。参与者反馈系统(PFS)可以通过授权参与者评估他们的研究经验并与研究人员分享反馈以确定改进的目标来对抗这种衰退。PFS表明参与者的体验是优先的,使反馈请求本身成为一种干预。PFS的设计工作仍然主要局限于临床研究。本探索性研究探讨了将PFS扩展到非临床研究的设计参数。我们对非临床利益相关者进行了焦点小组讨论:有经验的研究参与者(ERP)和研究团队成员(RTM)。方法:ERP焦点组按亲和力分组(LGBTQIA+组、BIPOC组、残疾人组、神经发散组和普通组)。RTM焦点小组是由密歇根大学内的单位组织的。对转录本进行归纳主题分析。结果:10个焦点小组(ERP: 5, n = 25; RTM: 5, n = 26)确定了PFS设计的关键考虑因素:(1)反馈的动机,(2)反馈的收集,(3)反馈的传递。ERP和RTM共同倾向于匿名的基于网络的调查,有六个潜在的主题领域:沟通、尊重、被重视、接受价值、负担和安全。反馈传递面临着两个关键的设计紧张关系:平衡机构标准化与特定研究的见解,使领导层对高级摘要的偏好与一线员工对详细、实时反馈的需求保持一致。结论:将PFS扩展到非临床研究需要平衡集中化和研究特异性灵活性。虽然集中加强了一致性,但非临床研究的多样性需要适应性实施。提出了一种优化可行性的混合模型。未来的研究应该完善和测试这个模型。
{"title":"Extending participant feedback beyond clinical studies: A modular system designed to connect researchers and participants.","authors":"Alicia Giordimaina Carmichael, Donna Walter, Brandon Patric Labbree, Boluwatife Dogari, Natalie Leonard, Kathryn Ward, Xiaoya Geng, Medha Raju, Jess Francis-Levin, Richard Gonzalez","doi":"10.1017/cts.2025.10184","DOIUrl":"10.1017/cts.2025.10184","url":null,"abstract":"<p><strong>Introduction: </strong>Declining participant engagement threatens human subjects research. Participant feedback systems (PFS) may combat this decline by empowering participants to evaluate their research experiences and share that feedback with researchers to identify targets for improvement. PFS signal that participant experiences are prioritized, making the request for feedback itself an intervention. PFS design work remains largely confined to clinical research. This exploratory study investigates the design parameters of extending PFS to nonclinical research. We conducted focus groups with nonclinical stakeholders: Experienced research participants (ERP) and research team members (RTM).</p><p><strong>Methods: </strong>ERP focus groups were organized by affinity (LGBTQIA+, BIPOC, persons with disabilities, neurodivergent, and a general group). RTM focus groups were organized by unit within the University of Michigan. Transcripts were analyzed using inductive thematic analysis.</p><p><strong>Results: </strong>Ten focus groups (ERP: 5, <i>n</i> = 25; RTM: 5, <i>n</i> = 26) identified key PFS design considerations: (1) motivations for feedback, (2) feedback collection, and (3) feedback delivery. ERP and RTM collectively preferred anonymous web-based surveys with six potential topic areas: communication, respect, being valued, receiving value, burden, and safety. Feedback delivery faced two key design tensions: balancing institutional standardization with study-specific insights and aligning leadership's preference for high-level summaries with frontline staff's need for detailed, real-time feedback.</p><p><strong>Conclusion: </strong>Expanding PFS to nonclinical research requires balancing centralization and study-specific flexibility. While centralization enhances consistency, the diversity of nonclinical studies necessitates adaptable implementation. A hybrid model is proposed to optimize feasibility. Future research should refine and test this model.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e258"},"PeriodicalIF":2.0,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Host gene expression in the Nasopharynx can discriminate microbiologically confirmed viral and bacterial lower respiratory tract infection. 宿主基因在鼻咽部的表达可以区分微生物学证实的病毒性和细菌性下呼吸道感染。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-29 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10191
L Gayani Tillekeratne, Nicholas O'Grady, Maria D Iglesias-Ussel, Jack Anderson, Alana Brown, Armstrong Obale, Christina Nix, Champica K Bodinayake, Ajith Nagahawatte, Robert Rolfe, E Wilbur Woodhouse, Gaya B Wijayaratne, Senali Weerasinghe, U H B Y Dilshan, Jayani Gamage, Ruvini Kurukulasooriya, Madureka Premamali, Himali S Jayasinghearachchi, Bradly P Nicholson, Emily R Ko, Ephraim L Tsalik, Micah T McClain, Rachel A Myers, Christopher W Woods, Thomas W Burke

Introduction: Distinguishing viral versus bacterial lower respiratory tract infection (LRTI) is challenging. We previously developed a rapid, host response-based test (Biomeme HR-B/V assay) using peripheral blood samples to identify viral versus bacterial infection. We assessed the performance of this assay when using nasopharyngeal (NP) samples.

Methods: Patients with LRTI were enrolled, and a NP swab sample was run using the HR-B/V assay (assessing 24 gene targets) on the FranklinTM platform. The performance of the prior classifier at identifying viral versus bacterial infection was assessed. A novel predictive model was generated for NP samples using the same 24 targets. Results were validated using external datasets with nasal/NP RNA sequence data.

Results: Nineteen patients (median age 62 years, 52.1% male) were included. When using the prior HR-B/V classifier on NP samples of 19 patients with LRTI (12 viral, 7 bacterial), the area under the receiver operator curve (AUC) for viral versus bacterial infection was 0.786 (0.524-1), with accuracy 0.79 (95% CI 0.57-0.91), positive percent agreement (PPA) 0.43 (95% CI 0.16-0.75), and negative percent agreement (NPA) 1.00 (95% CI 0.76-1). The novel model had AUC 0.881 (95% CI 0.726-1), accuracy 0.84 (95% CI 0.62-0.94), PPA 0.86 (95% CI 0.49-0.97), and NPA 0.83 (95% CI 0.55-0.95) for bacterial infection. Validation in two external datasets showed AUC of 0.932 (95% CI 0.90-0.96) and 0.915 (95% CI 0.88-0.95).

Conclusions: We show that host response in the nasopharynx can distinguish viral versus bacterial LRTI. These findings need to be replicated in larger cohorts with diverse LRTI etiologies.

区分病毒性和细菌性下呼吸道感染(LRTI)是具有挑战性的。我们之前开发了一种基于宿主反应的快速测试(Biomeme HR-B/V测定),使用外周血样本来识别病毒与细菌感染。我们在使用鼻咽(NP)样本时评估了该检测的性能。方法:纳入LRTI患者,在FranklinTM平台上使用HR-B/V法(评估24个基因靶点)对NP拭子样本进行检测。评估了先前分类器在识别病毒与细菌感染方面的性能。使用相同的24个目标,对NP样本生成了一个新的预测模型。使用鼻腔/NP RNA序列数据的外部数据集验证结果。结果:纳入19例患者(中位年龄62岁,男性52.1%)。当使用先前的HR-B/V分类器对19例LRTI患者(12例病毒,7例细菌)的NP样本进行分类时,病毒与细菌感染的接受者操作曲线下面积(AUC)为0.786(0.524-1),准确率为0.79 (95% CI 0.57-0.91),阳性一致性百分比(PPA)为0.43 (95% CI 0.16-0.75),阴性一致性百分比(NPA)为1.00 (95% CI 0.76-1)。该新型模型对细菌感染的AUC为0.881 (95% CI 0.726-1),准确度为0.84 (95% CI 0.62-0.94), PPA为0.86 (95% CI 0.49-0.97), NPA为0.83 (95% CI 0.55-0.95)。两个外部数据集的验证显示AUC分别为0.932 (95% CI 0.90-0.96)和0.915 (95% CI 0.88-0.95)。结论:鼻咽部的宿主反应可以区分病毒性和细菌性下呼吸道感染。这些发现需要在具有不同LRTI病因的更大队列中得到重复。
{"title":"Host gene expression in the Nasopharynx can discriminate microbiologically confirmed viral and bacterial lower respiratory tract infection.","authors":"L Gayani Tillekeratne, Nicholas O'Grady, Maria D Iglesias-Ussel, Jack Anderson, Alana Brown, Armstrong Obale, Christina Nix, Champica K Bodinayake, Ajith Nagahawatte, Robert Rolfe, E Wilbur Woodhouse, Gaya B Wijayaratne, Senali Weerasinghe, U H B Y Dilshan, Jayani Gamage, Ruvini Kurukulasooriya, Madureka Premamali, Himali S Jayasinghearachchi, Bradly P Nicholson, Emily R Ko, Ephraim L Tsalik, Micah T McClain, Rachel A Myers, Christopher W Woods, Thomas W Burke","doi":"10.1017/cts.2025.10191","DOIUrl":"10.1017/cts.2025.10191","url":null,"abstract":"<p><strong>Introduction: </strong>Distinguishing viral versus bacterial lower respiratory tract infection (LRTI) is challenging. We previously developed a rapid, host response-based test (Biomeme HR-B/V assay) using peripheral blood samples to identify viral versus bacterial infection. We assessed the performance of this assay when using nasopharyngeal (NP) samples.</p><p><strong>Methods: </strong>Patients with LRTI were enrolled, and a NP swab sample was run using the HR-B/V assay (assessing 24 gene targets) on the Franklin<sup>TM</sup> platform. The performance of the prior classifier at identifying viral versus bacterial infection was assessed. A novel predictive model was generated for NP samples using the same 24 targets. Results were validated using external datasets with nasal/NP RNA sequence data.</p><p><strong>Results: </strong>Nineteen patients (median age 62 years, 52.1% male) were included. When using the prior HR-B/V classifier on NP samples of 19 patients with LRTI (12 viral, 7 bacterial), the area under the receiver operator curve (AUC) for viral versus bacterial infection was 0.786 (0.524-1), with accuracy 0.79 (95% CI 0.57-0.91), positive percent agreement (PPA) 0.43 (95% CI 0.16-0.75), and negative percent agreement (NPA) 1.00 (95% CI 0.76-1). The novel model had AUC 0.881 (95% CI 0.726-1), accuracy 0.84 (95% CI 0.62-0.94), PPA 0.86 (95% CI 0.49-0.97), and NPA 0.83 (95% CI 0.55-0.95) for bacterial infection. Validation in two external datasets showed AUC of 0.932 (95% CI 0.90-0.96) and 0.915 (95% CI 0.88-0.95).</p><p><strong>Conclusions: </strong>We show that host response in the nasopharynx can distinguish viral versus bacterial LRTI. These findings need to be replicated in larger cohorts with diverse LRTI etiologies.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e257"},"PeriodicalIF":2.0,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Operationalizing community engagement evaluation: A structured and scalable approach using the RE-AIM framework and net effects diagrams. 实施社区参与评估:使用RE-AIM框架和净效益图的结构化和可扩展方法。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-29 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10190
Brian Do-Golden, Nicole Wolfe, Nicole M G Maccalla, James Settles, Michele D Kipke

Introduction: Community engagement (CE) is essential in Clinical and Translational Science (CTS), yet its evaluation remains inconsistent and often lacks standardization. The RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance) offers a promising structure for evaluating CE efforts, but its application in dynamic, community-based contexts is often limited by data variability and implementation complexity.

Methods: We developed and applied a seven-step, structured, and replicable approach to operationalizing RE-AIM for program evaluation. This method includes the use of tailored RE-AIM subdomains, standardized scoring systems, and visual analytics through Net Effects Diagrams.

Results: We applied this framework to our community-based health education workshops delivered in English and Spanish across Los Angeles, using participant surveys and facilitator feedback data. The operationalized framework enabled consistent assessment and comparison between language groups. Spanish-language workshops outperformed English-language workshops (ELWs) in measures of attendance, participant satisfaction, and short-term effectiveness. Visualizations using Net Effects Diagrams facilitated collaboration among stakeholders to interpret program outputs and outcomes, supporting actionable insights for program adaptation. Differences between workshop groups will inform changes to recruitment and content delivery strategies in ELWs.

Conclusions: This approach offers a transparent, scalable, and context-sensitive method for assessing CE programs. It supports data-driven decision-making, continuous program improvement, and stakeholder engagement. While developed for CE initiatives, the method is broadly adaptable to other community and public health programs. Future efforts will include expanded outcome tracking, integration into dashboards, and dissemination as a toolkit for broader adoption within and beyond the CTS Award network.

社区参与(CE)在临床和转化科学(CTS)中是必不可少的,但其评估仍然不一致,往往缺乏标准化。RE-AIM框架(Reach、Effectiveness、Adoption、Implementation、Maintenance)为评估CE工作提供了一个很有前途的结构,但是它在动态的、基于社区的环境中的应用常常受到数据可变性和实现复杂性的限制。方法:我们开发并应用了一个七步、结构化和可复制的方法来实施RE-AIM项目评估。该方法包括使用定制的RE-AIM子域、标准化评分系统,以及通过净效应器图进行可视化分析。结果:我们利用参与者调查和主持人反馈数据,将这一框架应用于洛杉矶以英语和西班牙语授课的社区健康教育研讨会。可操作的框架使语言群体之间的评估和比较保持一致。在出勤率、参与者满意度和短期有效性方面,西班牙语研讨会优于英语研讨会。使用净效应图的可视化促进了利益相关者之间的协作,以解释项目输出和结果,为项目适应提供可操作的见解。研讨会小组之间的差异将为低成本网络的招聘和内容交付策略的变化提供信息。结论:该方法为评估CE项目提供了一种透明、可扩展和上下文敏感的方法。它支持数据驱动的决策、持续的计划改进和涉众参与。虽然该方法是为环境卫生项目开发的,但它也广泛适用于其他社区和公共卫生项目。未来的工作将包括扩大结果跟踪,整合到仪表板中,并作为工具包传播,以便在CTS奖励网络内外更广泛地采用。
{"title":"Operationalizing community engagement evaluation: A structured and scalable approach using the RE-AIM framework and net effects diagrams.","authors":"Brian Do-Golden, Nicole Wolfe, Nicole M G Maccalla, James Settles, Michele D Kipke","doi":"10.1017/cts.2025.10190","DOIUrl":"10.1017/cts.2025.10190","url":null,"abstract":"<p><strong>Introduction: </strong>Community engagement (CE) is essential in Clinical and Translational Science (CTS), yet its evaluation remains inconsistent and often lacks standardization. The RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance) offers a promising structure for evaluating CE efforts, but its application in dynamic, community-based contexts is often limited by data variability and implementation complexity.</p><p><strong>Methods: </strong>We developed and applied a seven-step, structured, and replicable approach to operationalizing RE-AIM for program evaluation. This method includes the use of tailored RE-AIM subdomains, standardized scoring systems, and visual analytics through Net Effects Diagrams.</p><p><strong>Results: </strong>We applied this framework to our community-based health education workshops delivered in English and Spanish across Los Angeles, using participant surveys and facilitator feedback data. The operationalized framework enabled consistent assessment and comparison between language groups. Spanish-language workshops outperformed English-language workshops (ELWs) in measures of attendance, participant satisfaction, and short-term effectiveness. Visualizations using Net Effects Diagrams facilitated collaboration among stakeholders to interpret program outputs and outcomes, supporting actionable insights for program adaptation. Differences between workshop groups will inform changes to recruitment and content delivery strategies in ELWs.</p><p><strong>Conclusions: </strong>This approach offers a transparent, scalable, and context-sensitive method for assessing CE programs. It supports data-driven decision-making, continuous program improvement, and stakeholder engagement. While developed for CE initiatives, the method is broadly adaptable to other community and public health programs. Future efforts will include expanded outcome tracking, integration into dashboards, and dissemination as a toolkit for broader adoption within and beyond the CTS Award network.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e255"},"PeriodicalIF":2.0,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Badged up for success: Digital badges enable graduate students to become confident communicators via real-world opportunities and to document their skills for employers. 成功的标志:数字标志使研究生通过现实世界的机会成为自信的沟通者,并为雇主证明他们的技能。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-29 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10188
Kimberly McGhee, Matthew Greseth, Tammy Loucks, Paula Traktman

In January 2023, the South Carolina Science Writing Initiative for Trainees (SC-SWIFT), an internship in the College of Graduate Studies at the Medical University of South Carolina, began offering tiered digital badges in science communications. The badges' purpose was to encourage graduate students and postdoctoral fellows to engage in extracurricular science writing opportunities available through SC-SWIFT and to document acquired communications skills for employers. The badges have been well received, with 18 interns earning the beginner badge in the first two years of the program. In March 2025, SC-SWIFT queried 25 interns who had earned a beginner badge or completed half the requirements for doing so in 2023-2024 to gauge how important they considered the badges to their engagement in science communications and how valuable they would be in a job search. All 14 respondents found the badges important in engaging them in science communications, and 86% either strongly agreed or agreed that digital badges would be an asset when job searching. Eleven of 12 respondents (92%) thought that their confidence in telling their own research story had increased. These initial results suggest that digital badges could be useful tools for documenting science communications skills acquired during extracurricular, experiential learning.

2023年1月,南卡罗来纳医科大学研究生学院的实习生南卡罗来纳科学写作倡议(SC-SWIFT)开始在科学传播中提供分层数字徽章。这些徽章的目的是鼓励研究生和博士后参与SC-SWIFT提供的课外科学写作机会,并为雇主记录他们获得的沟通技巧。这些徽章受到了好评,在项目的头两年,有18名实习生获得了初学者徽章。2025年3月,SC-SWIFT询问了25名获得初学者徽章或在2023-2024年完成了一半要求的实习生,以衡量他们认为徽章对他们参与科学传播的重要性以及他们在求职中的价值。所有14名受访者都认为数字徽章对他们参与科学传播很重要,86%的人强烈同意或同意数字徽章将是求职时的一项资产。12名受访者中有11人(92%)认为他们讲述自己研究故事的信心有所增加。这些初步结果表明,数字徽章可能是记录在课外体验式学习中获得的科学传播技能的有用工具。
{"title":"Badged up for success: Digital badges enable graduate students to become confident communicators via real-world opportunities and to document their skills for employers.","authors":"Kimberly McGhee, Matthew Greseth, Tammy Loucks, Paula Traktman","doi":"10.1017/cts.2025.10188","DOIUrl":"10.1017/cts.2025.10188","url":null,"abstract":"<p><p>In January 2023, the South Carolina Science Writing Initiative for Trainees (SC-SWIFT), an internship in the College of Graduate Studies at the Medical University of South Carolina, began offering tiered digital badges in science communications. The badges' purpose was to encourage graduate students and postdoctoral fellows to engage in extracurricular science writing opportunities available through SC-SWIFT and to document acquired communications skills for employers. The badges have been well received, with 18 interns earning the beginner badge in the first two years of the program. In March 2025, SC-SWIFT queried 25 interns who had earned a beginner badge or completed half the requirements for doing so in 2023-2024 to gauge how important they considered the badges to their engagement in science communications and how valuable they would be in a job search. All 14 respondents found the badges important in engaging them in science communications, and 86% either strongly agreed or agreed that digital badges would be an asset when job searching. Eleven of 12 respondents (92%) thought that their confidence in telling their own research story had increased. These initial results suggest that digital badges could be useful tools for documenting science communications skills acquired during extracurricular, experiential learning.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e254"},"PeriodicalIF":2.0,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engaging community health center advisors to identify research priorities for health equity. 与社区卫生中心顾问合作,确定卫生公平的研究重点。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10179
Nynikka R Palmer, Michael B Potter, Saji Mansur, Cecilia Hurtado, Maria Carbajal, Gary Bossier, Maria Echaveste, Paula Fleisher, Carlos Guerra-Sanchez, Stutee Khandelwal, Gena Lewis, Lali Moheno, Tung Nguyen, David Ofman, Kerrington Osborne, James D Harrison

Background: Community health centers (CHCs) and those most burdened by disease are important partners in setting research agendas to address the needs of people who are medically underserved.

Objectives: Identify and prioritize health equity-focused research priorities using a collaborative approach to community engagement of key informants.

Methods: We used five stepwise phases from January 2021 to February 2023 to formulate and prioritize a set of health equity-focused research topics among CHC staff (leaders, clinicians), their key advisors (patients and community members), and researchers from academic medical centers in California. Phases included: (1) community advisory board formation, (2) key informant identification, (3) individual/small group interview guide development and administration, (4) initial health equity-focused topic categorization, and (5) in-person meeting with community advisors for final topic prioritization using nominal group technique.

Results: Twenty individual or small group interviews were completed with 44 diverse participants, along with engagement from our community advisory board, which resulted in an initial list of 11 health equity-focused research topics. Ninety advisors including diverse community members, CHC staff/leaders, and researchers prioritized six overarching research topics. Final prioritized health-equity focused research topics include addressing mental health challenges, improving public's trust in healthcare and science, healthcare delivery models to increase access and utilization, build and sustain an anti-racist healthcare system, strategies and interventions to address health misinformation, and continuing and sustaining polices based on lessons learned from COVID-19.

Conclusions: Results offer future direction for community-engaged research agendas to advance health equity among medically underserved and vulnerable patient populations.

背景:社区卫生中心(CHCs)和疾病负担最重的社区卫生中心是制定研究议程以解决医疗服务不足人群需求的重要合作伙伴。目标:采用协作方式,让主要举报人参与社区活动,确定以卫生公平为重点的研究重点,并确定其优先次序。方法:从2021年1月至2023年2月,我们采用五个逐步阶段,在加州CHC员工(领导者、临床医生)、他们的主要顾问(患者和社区成员)和学术医疗中心的研究人员中制定并优先考虑一系列以卫生公平为重点的研究课题。阶段包括:(1)社区咨询委员会的组建;(2)关键信息提供者的识别;(3)个人/小组访谈指导发展和管理;(4)初步以卫生公平为重点的主题分类;(5)与社区顾问面对面会议,使用名义上的小组技术确定最终的主题优先级。结果:与44名不同的参与者一起完成了20次个人或小组访谈,以及我们社区顾问委员会的参与,最终得出了11个以卫生公平为重点的研究主题的初步清单。包括不同社区成员、CHC工作人员/领导和研究人员在内的90名顾问优先考虑了六个总体研究主题。最终确定的以卫生公平为重点的优先研究课题包括:应对精神卫生挑战、提高公众对医疗保健和科学的信任、提高获取和利用的医疗保健服务模式、建立和维持反种族主义医疗保健系统、解决卫生错误信息的战略和干预措施,以及基于2019冠状病毒病的经验教训继续和维持政策。结论:结果为社区参与的研究议程提供了未来的方向,以促进医疗服务不足和弱势患者群体的健康公平。
{"title":"Engaging community health center advisors to identify research priorities for health equity.","authors":"Nynikka R Palmer, Michael B Potter, Saji Mansur, Cecilia Hurtado, Maria Carbajal, Gary Bossier, Maria Echaveste, Paula Fleisher, Carlos Guerra-Sanchez, Stutee Khandelwal, Gena Lewis, Lali Moheno, Tung Nguyen, David Ofman, Kerrington Osborne, James D Harrison","doi":"10.1017/cts.2025.10179","DOIUrl":"10.1017/cts.2025.10179","url":null,"abstract":"<p><strong>Background: </strong>Community health centers (CHCs) and those most burdened by disease are important partners in setting research agendas to address the needs of people who are medically underserved.</p><p><strong>Objectives: </strong>Identify and prioritize health equity-focused research priorities using a collaborative approach to community engagement of key informants.</p><p><strong>Methods: </strong>We used five stepwise phases from January 2021 to February 2023 to formulate and prioritize a set of health equity-focused research topics among CHC staff (leaders, clinicians), their key advisors (patients and community members), and researchers from academic medical centers in California. Phases included: (1) community advisory board formation, (2) key informant identification, (3) individual/small group interview guide development and administration, (4) initial health equity-focused topic categorization, and (5) in-person meeting with community advisors for final topic prioritization using nominal group technique.</p><p><strong>Results: </strong>Twenty individual or small group interviews were completed with 44 diverse participants, along with engagement from our community advisory board, which resulted in an initial list of 11 health equity-focused research topics. Ninety advisors including diverse community members, CHC staff/leaders, and researchers prioritized six overarching research topics. Final prioritized health-equity focused research topics include addressing mental health challenges, improving public's trust in healthcare and science, healthcare delivery models to increase access and utilization, build and sustain an anti-racist healthcare system, strategies and interventions to address health misinformation, and continuing and sustaining polices based on lessons learned from COVID-19.</p><p><strong>Conclusions: </strong>Results offer future direction for community-engaged research agendas to advance health equity among medically underserved and vulnerable patient populations.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e253"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: EHRchitect: An open-source software tool for medical event sequences data extraction from Electronic Health Records - CORRIGENDUM. 从电子健康记录中提取医疗事件序列数据的开源软件工具-勘误表。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10183
Kostiantyn Botnar, Justin T Nguyen, Madison G Farnswort, George Golovko, Kamil Khanipov

[This corrects the article DOI: 10.1017/cts.2025.55.].

[这更正了文章DOI: 10.1017/cts.2025.55]。
{"title":"Erratum: EHRchitect: An open-source software tool for medical event sequences data extraction from Electronic Health Records - CORRIGENDUM.","authors":"Kostiantyn Botnar, Justin T Nguyen, Madison G Farnswort, George Golovko, Kamil Khanipov","doi":"10.1017/cts.2025.10183","DOIUrl":"10.1017/cts.2025.10183","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1017/cts.2025.55.].</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e242"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the science and practice of effective mentorship. 推进有效指导的科学和实践。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10168
Christine Pfund, Christine Sorkness, David Asai, Marcus Lambert, Emma Anne Meagher, Audrey J Murrell, Nancy Schwartz, Joel Tsevat
{"title":"Advancing the science and practice of effective mentorship.","authors":"Christine Pfund, Christine Sorkness, David Asai, Marcus Lambert, Emma Anne Meagher, Audrey J Murrell, Nancy Schwartz, Joel Tsevat","doi":"10.1017/cts.2025.10168","DOIUrl":"10.1017/cts.2025.10168","url":null,"abstract":"","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e238"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and pilot of a tool evaluating community-engaged group processes and community-centered impact for institutional level advisory boards. 为机构级咨询委员会开发和试点一种工具,评估社区参与的小组进程和以社区为中心的影响。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10177
Michele Allen, Yasamin Graff, Caroline Carlin, Antonia Apolinario-Wilcoxon, Paulette Baukol, Kristin Boman, LaPrincess Brewer, Roli Dwivedi, Milton Eder, Susan Gust, Mikow Hang, Walter Novillo, Luis Ortega, Shannon Pergament, Chris Pulley, Rebecca Shirley, Sida Ly-Xiong

Introduction: While evaluation approaches for community-academic research groups are established, few tools exist for academic institutional advisory groups across multi-core centers and research, education, and clinical care missions. Institutional advisory group evaluation should consider group processes and their impact on community-centered outcomes. This study describes the community-engaged development of a mixed-method evaluation approach to address this gap and presents pilot outcomes across an NIH-funded center.

Methods: We utilized a Community of Practice model to co-develop a survey with 14 community and academic representatives of four advisory groups. The final survey included five categories of group process and four categories of outcomes. Storytelling sessions with community partners explored areas where the survey identified discrepancies in perspectives between community and academic team members, as well as areas with lower scores.

Results: Nine community and 14 academic (staff and faculty) partners completed the survey. Respondents positively assessed group process outcomes (shared values, leadership, community-centeredness, and decision-making), and slightly less positive assessments of institutional outcomes. Storytelling sessions confirmed the overall satisfaction of community partners but highlighted actionable concerns within power-sharing, decision-making, funding equity, and trust-building.

Conclusions: The results of this equity-centered evaluation suggest the utility and importance of participatory, mixed-methods approaches to evaluating community-academic institutional advisory groups.

虽然社区学术研究小组的评估方法已经建立,但对于跨多核心中心和研究、教育和临床护理任务的学术机构咨询小组,很少有工具存在。机构咨询小组评估应考虑小组过程及其对以社区为中心的结果的影响。本研究描述了社区参与的一种混合方法评估方法的发展,以解决这一差距,并介绍了美国国立卫生研究院资助中心的试点结果。方法:我们利用实践社区模型与四个咨询小组的14个社区和学术代表共同开发了一项调查。最后的调查包括五类小组过程和四类结果。与社区伙伴的讲故事会议探讨了调查发现社区和学术团队成员之间观点差异的领域,以及得分较低的领域。结果:9个社区和14个学术(教职员工)合作伙伴完成了调查。受访者积极评价群体过程结果(共同价值观、领导力、以社区为中心和决策),对机构结果的积极评价略低。讲故事会议确认了社区合作伙伴的总体满意度,但强调了在权力分享、决策、资金公平和建立信任方面的可操作性问题。结论:这项以公平为中心的评估结果表明,参与式、混合方法方法对评估社区-学术机构咨询小组的效用和重要性。
{"title":"Development and pilot of a tool evaluating community-engaged group processes and community-centered impact for institutional level advisory boards.","authors":"Michele Allen, Yasamin Graff, Caroline Carlin, Antonia Apolinario-Wilcoxon, Paulette Baukol, Kristin Boman, LaPrincess Brewer, Roli Dwivedi, Milton Eder, Susan Gust, Mikow Hang, Walter Novillo, Luis Ortega, Shannon Pergament, Chris Pulley, Rebecca Shirley, Sida Ly-Xiong","doi":"10.1017/cts.2025.10177","DOIUrl":"10.1017/cts.2025.10177","url":null,"abstract":"<p><strong>Introduction: </strong>While evaluation approaches for community-academic research groups are established, few tools exist for academic institutional advisory groups across multi-core centers and research, education, and clinical care missions. Institutional advisory group evaluation should consider group processes and their impact on community-centered outcomes. This study describes the community-engaged development of a mixed-method evaluation approach to address this gap and presents pilot outcomes across an NIH-funded center.</p><p><strong>Methods: </strong>We utilized a Community of Practice model to co-develop a survey with 14 community and academic representatives of four advisory groups. The final survey included five categories of group process and four categories of outcomes. Storytelling sessions with community partners explored areas where the survey identified discrepancies in perspectives between community and academic team members, as well as areas with lower scores.</p><p><strong>Results: </strong>Nine community and 14 academic (staff and faculty) partners completed the survey. Respondents positively assessed group process outcomes (shared values, leadership, community-centeredness, and decision-making), and slightly less positive assessments of institutional outcomes. Storytelling sessions confirmed the overall satisfaction of community partners but highlighted actionable concerns within power-sharing, decision-making, funding equity, and trust-building.</p><p><strong>Conclusions: </strong>The results of this equity-centered evaluation suggest the utility and importance of participatory, mixed-methods approaches to evaluating community-academic institutional advisory groups.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e261"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing translational science through trial integrity: REDCap-based approaches to mitigating fraud and bias. 通过试验完整性推进转化科学:基于redcap的减少欺诈和偏见的方法。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10176
Gaylen E Fronk, Larry W Hawk, Andrew Cates, John Clark, Noelle Natale, Jennifer Dahne

Decentralized clinical trials (DCTs) have the potential to increase pace and reach of recruitment as well as to improve sample representation, compared to traditional in-person clinical trials. However, concerns linger regarding data integrity in DCTs due to threats of fraud and sampling bias. The purpose of this report is to describe two tools that we have developed and successfully implemented to combat these threats. Cheatblocker and QuotaConfig are two external modules that we have made publicly available within the REDCap data capture system to target fraud and sampling bias, respectively. We describe the modules, present two case examples in which we used the modules successfully, and discuss the potential impact of tools such as these on data integrity in DCTs. We situate this discussion within the broader landscape of translational science wherein we strive to improve research rigor and efficiency to maximize public health benefit.

与传统的面对面临床试验相比,分散临床试验(dct)有可能加快招募的速度和范围,并改善样本代表性。然而,由于欺诈和抽样偏差的威胁,对dct数据完整性的担忧仍然存在。本报告的目的是描述我们开发并成功实施的两种工具,以对抗这些威胁。Cheatblocker和quotacconfig是我们在REDCap数据捕获系统中公开提供的两个外部模块,分别用于针对欺诈和抽样偏差。我们描述了这些模块,给出了我们成功使用这些模块的两个案例,并讨论了这些工具对dct中数据完整性的潜在影响。我们将这一讨论置于转化科学的更广阔的前景中,其中我们努力提高研究的严密性和效率,以最大限度地提高公共卫生效益。
{"title":"Advancing translational science through trial integrity: REDCap-based approaches to mitigating fraud and bias.","authors":"Gaylen E Fronk, Larry W Hawk, Andrew Cates, John Clark, Noelle Natale, Jennifer Dahne","doi":"10.1017/cts.2025.10176","DOIUrl":"10.1017/cts.2025.10176","url":null,"abstract":"<p><p>Decentralized clinical trials (DCTs) have the potential to increase pace and reach of recruitment as well as to improve sample representation, compared to traditional in-person clinical trials. However, concerns linger regarding data integrity in DCTs due to threats of fraud and sampling bias. The purpose of this report is to describe two tools that we have developed and successfully implemented to combat these threats. Cheatblocker and QuotaConfig are two external modules that we have made publicly available within the REDCap data capture system to target fraud and sampling bias, respectively. We describe the modules, present two case examples in which we used the modules successfully, and discuss the potential impact of tools such as these on data integrity in DCTs. We situate this discussion within the broader landscape of translational science wherein we strive to improve research rigor and efficiency to maximize public health benefit.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e252"},"PeriodicalIF":2.0,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accelerating start-up cycles in investigator-initiated multicenter clinical trials. 加速研究者发起的多中心临床试验的启动周期。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10180
Shannon Hillery, Ryan Majkowski, Ying Wang, Bradley Barney, Lindsay Eyzaguirre, Andrew Mould, Nichol McBee, Esther Woo, Elizabeth Holthouse, Kenneth Wiley, Salina P Waddy, Daniel Ford, Daniel F Hanley, Karen Lane

Background: Operational roadblocks and organizational delays in multicenter clinical trials have been evident for decades, with the start-up cycle being especially notorious for setbacks. To address these challenges and improve multicenter clinical trial execution, we developed an accelerated start-up (ASU) management strategy - a structured site onboarding approach based on lean management principles.

Methods: Three elements were integrated into the strategy: a standardized workflow, a dedicated site navigator (SN), and an electronic tracking system. We examined the range, central tendencies, and distribution of site activation times among differing combinations of these three elements. To determine how these combinations affected individual start-up milestones, we fit mixed models to compare percent achievement of predetermined milestone benchmarks and time to completion.

Results: Thirteen consecutive trials (n = 308 site activations) employed three distinct combinations of the three ASU elements. Trials using all three elements (n = 6) had 160 total site activations in a median of 133 days. Three trials without the SN element had 52 total site activations in a median of 191 days. Four trials without the standardized workflow element had 96 total site activations in a median of 277 days. Significant differences between combinations included times to sIRB submission (p = 0.004), training/certificates completion (p = 0.03), and site activation (p = 0.003). Results suggest sites activated faster and achieved predetermined benchmarks for every milestone more often when three elements were employed.

Conclusion: This sample trial start-up data supports that sites can meet ambitious timelines, underscoring the strategy's potential to streamline workflows and improve site team performance.

背景:几十年来,多中心临床试验的操作障碍和组织延迟已经很明显,启动周期尤其以挫折而臭名昭著。为了应对这些挑战并改善多中心临床试验的执行,我们开发了一种加速启动(ASU)管理策略——一种基于精益管理原则的结构化站点入职方法。方法:将三个要素整合到策略中:标准化工作流程,专用站点导航器(SN)和电子跟踪系统。我们检查了这三个元素的不同组合的范围,中心趋势和站点激活时间的分布。为了确定这些组合如何影响单个启动里程碑,我们拟合混合模型来比较预定里程碑基准的实现百分比和完成时间。结果:13个连续试验(n = 308个位点激活)采用了三种不同的ASU元素组合。使用所有三种元素的试验(n = 6)在133天的中位时间内总共激活了160个位点。没有SN元件的三个试验在191天的中位时间内总共激活了52个位点。没有标准化工作流程元素的四项试验在277天的中位数内总共激活了96个站点。组合之间的显著差异包括sIRB提交时间(p = 0.004)、培训/证书完成时间(p = 0.03)和位点激活时间(p = 0.003)。结果表明,当使用三个元素时,站点激活速度更快,并且更经常地达到每个里程碑的预定基准。结论:该样本试验启动数据支持站点可以满足雄心勃勃的时间表,强调该策略在简化工作流程和提高站点团队绩效方面的潜力。
{"title":"Accelerating start-up cycles in investigator-initiated multicenter clinical trials.","authors":"Shannon Hillery, Ryan Majkowski, Ying Wang, Bradley Barney, Lindsay Eyzaguirre, Andrew Mould, Nichol McBee, Esther Woo, Elizabeth Holthouse, Kenneth Wiley, Salina P Waddy, Daniel Ford, Daniel F Hanley, Karen Lane","doi":"10.1017/cts.2025.10180","DOIUrl":"10.1017/cts.2025.10180","url":null,"abstract":"<p><strong>Background: </strong>Operational roadblocks and organizational delays in multicenter clinical trials have been evident for decades, with the start-up cycle being especially notorious for setbacks. To address these challenges and improve multicenter clinical trial execution, we developed an accelerated start-up (ASU) management strategy - a structured site onboarding approach based on lean management principles.</p><p><strong>Methods: </strong>Three elements were integrated into the strategy: a standardized workflow, a dedicated site navigator (SN), and an electronic tracking system. We examined the range, central tendencies, and distribution of site activation times among differing combinations of these three elements. To determine how these combinations affected individual start-up milestones, we fit mixed models to compare percent achievement of predetermined milestone benchmarks and time to completion.</p><p><strong>Results: </strong>Thirteen consecutive trials (<i>n</i> = 308 site activations) employed three distinct combinations of the three ASU elements. Trials using all three elements (<i>n</i> = 6) had 160 total site activations in a median of 133 days. Three trials without the SN element had 52 total site activations in a median of 191 days. Four trials without the standardized workflow element had 96 total site activations in a median of 277 days. Significant differences between combinations included times to sIRB submission (<i>p</i> = 0.004), training/certificates completion (<i>p</i> = 0.03), and site activation (<i>p</i> = 0.003). Results suggest sites activated faster and achieved predetermined benchmarks for every milestone more often when three elements were employed.</p><p><strong>Conclusion: </strong>This sample trial start-up data supports that sites can meet ambitious timelines, underscoring the strategy's potential to streamline workflows and improve site team performance.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e249"},"PeriodicalIF":2.0,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical and Translational Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1